Gynecologic Cancers

General Rheumatology

Questions discussed in this category

When a patient with a preexisting rheumatic disease and on immunotherapy begins to flare, how do you decide if this is an underlying rheumatic disease activity versus an immunotherapy related adverse event?

How do you decide if it may be safe to continue immunotherapy?

1 Answer available

Related Topics in Gynecologic Cancers